Due to the growing population of dry eye patients, there has been much study of dry eye disease. Following the full reports of the International Dry Eye Workshops of 2007 and 2017 (DEWS I and II), as well as the recent Dry Eye Assessment and Management (DREAM) trial, there is a growing body of consensus and evidence-based literature on the treatment of dry eye. Dry Eye Disease: A Practical Guide synthesizes all these scientific sources into a comprehensive, yet, user-friendly clinical reference. From epidemiology and pathogenesis, to disease subgroups, diagnostics, and management, Drs. Francis Mah and Michelle Rhee with their team of over 35 renowned contributors have distilled all the latest information on dry eye disease into an easily digestible guide. Featuring diverse case scenarios pulled from clinical practice, Dry Eye Disease engages the reader and encourages critical thinking to apply current understanding of dry eye disease to the office and operating room. All aspects of this complex disease are discussed, including the relationship between dry eye and surgical outcomes and contact lens wear. Some topics include: The latest biomarker diagnostics Meibomian gland dysfunction therapeutic technologies The role of integrative medicine Advances in therapeutic contact lenses Ophthalmologists and optometrists of all specialties and skill levels will find Dry Eye Disease: A Practical Guide a comprehensive yet practical clinical guide for treating the growing population of dry eye patients.

trial was presented at the American Society of Cataract and Refractive Surgery meeting in Washington DC. After its publication in The New England Journal of Medicine1, we reassessed our text, especially with regard to the use of omega-3 fatty acids. We applaud the researchers’ diligence in examining the value of omega-3 fatty acids. While this study certainly enhances our understanding of dry eye disease, it does not obviate the use of all omega-3 fatty acids, which remain an important treatment option for dry eye disease. We are grateful to our expert and experienced contributing authors for the hard work and generous thoughtfulness put into sharing their knowledge. To reflect a diversity of perspectives, we recruited leaders in the field throughout North America from a variety of practice settings including university-based and private.

Clinically-oriented and up-to-date, Dry Eye Diseases focuses on the latest diagnostic techniques, management guidelines, and treatment options for dry eye disorders. This consolidated resource provides guidance on the clinical assessment of patients presenting with dry eye symptoms as well as a global perspectives on the use of FDA and off-label products. Practicing and trainee ophthalmologists and optometrists will find this an indispensable resource for understanding this complex disorder. - Covers a range of topics, including clinical assessment, pathophysiology, the link between dry eye and system disease, and the use of FDA and off-label products as treatment options for dry eye diseases. - Includes a section devoted to the presence of dry eye disease in specific populations, including patients presenting with other ocular conditions, systemic pain conditions, graft-versus-host disease, Sjögren's syndrome, and meibomian gland dysfunction. - Addresses the challenges associated with treating ocular pain not responsive to traditional dry eye disease treatments. - Features concise chapters from a team of international chapter authors, providing global perspectives on this common disorder. - Consolidates today's available information on this timely topic into a single, convenient resource.

Dry eye is one of the most common disorders encountered in ophthalmological practice. Its symptoms cause considerable discomfort and substantially reduce the patient's quality of life. As it is a complex and multifactorial condition, research investigating dry eye is a matter of great interest all over the world. In this book, the wide range of current basic and clinical research in dry eye and correlated ocular surface diseases is presented by scientists from Germany, Austria and the USA. These renowned authors provide clear and extensive descriptions of their projects, enabling scientists and clinical ophthalmologists to quickly bring themselves up to date with cutting edge research in this field. This overview of research into the pathogenesis and clinical treatment of dry eye is a must for all ophthalmologists dealing with this syndrome and looking to increase their knowledge base.

This text presents cutting-edge topics on and the diagnostic and therapeutic approaches for tear film abnormities, including dry eye disease and Meibomian gland dysfunction. A new management algorithm for Meibomian gland dysfunction, therapeutic eye drops and intense pulsed lasers for dry eye disease, and topical and systemic agents for neuropathic ocular pain are proposed in this issue.

This book examines the impact of climate change on eye disease and eye health. Filling a lacuna in the existing literature, Scott Fraser takes a deep dive into the eye diseases that are most affected by the climate crisis and explores the subsequent burden on organisations, charities and healthcare systems. Fraser begins by including short primer chapters on the basics of climate science and climate change, highlighting which environmental mechanisms directly and indirectly affect our health and why. He then looks in detail at the direct and indirect threats to eye health from climate change and examines factors including changing insect vectors, trauma from extreme weather events such as wildfires, floods and droughts, as well as the impact of crop failure, malnutrition, animal and plant migration. Highlighting the Global North vs South divide, the book goes on to consider issues around eye care, exploring the increased burden that climate-induced chronic eye diseases including cataracts, macular degeneration and nutritional eye diseases are placing on health care systems. These chapters also reflect on the ways in which eye care, ophthalmology, optometry, pharmaceutical and medical device companies all contribute to the climate footprint themselves. Unique and timely, this book will be a great resource for students and clinicians of ophthalmology, optometry and allied eye care professions, as well as climate scientists, researchers, policy makers, charities, NGOs working in related fields of environment and health.

Eye Diseases: New Insights for the Healthcare Professional: 2013 Edition is a ScholarlyEditions™ book that delivers timely, authoritative, and comprehensive information about Diagnosis and Screening. The editors have built Eye Diseases: New Insights for the Healthcare Professional: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Diagnosis and Screening in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Eye Diseases: New Insights for the Healthcare Professional: 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.